CAM PHARMA
Dissolved and wound up on 26-03-2026Deeds, filings and financial milestones
2026
15-04
Gazette deed
Dissolution with immediate closure of the liquidationDissolved and wound up in a single deed on 26-03-2026 · No liquidator appointed · Books and records kept in Waardamme4 points ▸
Gazette deed
Dissolution with immediate closure of the liquidation
Dissolved and wound up in a single deed on 26-03-2026 · No liquidator appointed · Books and records kept in Waardamme4 points ▸
- General meeting, 26-03-2026
- Director resignation, Camille DELTOMME
- Director discharge, Camille DELTOMME
- Liquidation closure, 26-03-2026
- The deed holds 10 more points.
14-04
micro format · 195 days before the deadline
26-03
Financial
Weakest financial yearnet -€6,823
The net result drops to -€6,823, the lowest from 2023 to 2026.
16-02
micro format · 165 days before the deadline
2025
30-06
micro format · 31 days before the deadline
2024
31-12
Financial
Liquidity more than 8 timescurrent ratio 37.52
The current ratio rises from 4.24 to 37.52. Short-term debt falls from €7,168 to €673.
10-07
micro format · 21 days before the deadline
2022
13-09
Gazette deed
IncorporationFounding capital of €1,000, 50 shares · Founder: DELTOMME Camille Cathérine Christophe · Appointment: DELTOMME Camille Cathérine Christophe (director)4 points ▸
Gazette deed
Incorporation
Founding capital of €1,000, 50 shares · Founder: DELTOMME Camille Cathérine Christophe · Appointment: DELTOMME Camille Cathérine Christophe (director)4 points ▸
- Incorporation, 09-09-2022
- Founder, DELTOMME Camille Cathérine Christophe
- Founding capital, €1,000, 50 shares
- Director appointment, DELTOMME Camille Cathérine Christophe
- The deed holds 1 more point.
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank